Target intelligence / Profile preview

Major outer membrane protein (MOMP) (MOMP)

Target
MOMP
Molecular classification
Outer membrane protein, Porin, Beta-barrel protein, Antigen
01

Overview

The Major outer membrane protein (MOMP) is a critical structural and functional component of the outer membrane in Gram-negative bacteria, most notably within the genus Chlamydia. It is a 40-kDa cysteine-rich protein that functions as a porin, forming beta-barrel channels that facilitate the diffusion of essential solutes and nutrients across the bacterial envelope [5, 7, 11]. Beyond its transport role, MOMP is essential for maintaining the structural rigidity of the infectious elementary body (EB) through disulfide bond cross-linking and serves as a primary adhesin for host cell attachment and entry [4, 11, 19]. In clinical medicine, MOMP is the immunodominant antigen used to define Chlamydia trachomatis serovars and is the leading candidate for vaccine development due to its surface exposure and ability to elicit neutralizing antibodies [3, 8, 18]. Therapeutic strategies targeting MOMP include recombinant subunit vaccines and novel affitoxins designed to neutralize infection or deliver lethal payloads directly to the pathogen [2, 9, 18].

Other names
OmpAPorin40-kDa MOMPMajor outer membrane protein of Chlamydia trachomatisMajor outer membrane protein of Chlamydia psittaciMajor outer membrane protein of Chlamydia pneumoniae
02

Mechanism of action

Neutralization of bacterial infection by antibodies, induction of Th1 and Th17 immune responses, and pore-mediated delivery of toxins (for affitoxins)

03

Biological functions

Structural integrityNutrient transportCell adhesionHost cell entryAntigenic variationPorin activity
04

Disease associations

Chlamydia trachomatis infectionTrachomaLymphogranuloma venereumPneumoniaAtherosclerosisInfection
05

Safety considerations

Antigenic variation leading to serovar-specific immunityDifficulty in maintaining native protein conformation for vaccine efficacyPotential for immunopathogenesis
06

Interacting drugs

CTH522 (vaccine candidate)

2 more in the full profile.

07

Biomarkers

MOMP-specific IgGMOMP-specific IgAInterferon-gamma (IFN-gamma)Serovar-specific antibodies

Beyond the preview

Go deeper on Major outer membrane protein (MOMP) (MOMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major outer membrane protein (MOMP) (MOMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call